Abiopharma

Humacyte Announces Hospital Charge Data Showing High Expense of Preventable Extremity Arterial Injury Complications

Ensysce Biosciences Receives EU Patent Expanding its First-in-Class ADHD Therapy with Built-In Abuse and Overdose Protection

Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa

CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates

Humacyte Announces Hospital Charge Data Showing High Expense of Preventable Extremity Arterial Injury Complications

Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook

Collegium Provides 2026 Financial Guidance and Business Update

Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference

Reviva Announces Publication on Clinical Vocal Biomarker Data from the RECOVER Phase 3 Clinical Trial of Brilaroxazine to Treat Negative Symptoms in Schizophrenia

XWELL Reaffirms Commitment to Biosecurity, Appoints Former CDC Senior Advisor

New Form SCHEDULE 13G - JOINT Corp Filed: 2026-01-08 AccNo: 0001821268-26-000003 Size: 6 KB

Curaleaf Announces Proposed Domestication to Delaware

(90% Positive) Context Therapeutics Inc. (CNTX) Provides Update on reflected for such are reasonable

New Form ARS - Modular Medical, Inc. Filed: 2026-01-08 AccNo: 0001213900-26-002333 Size: 731 KB

New Form DEF 14A - Modular Medical, Inc. Filed: 2026-01-08 AccNo: 0001213900-26-002332 Size: 22 MB